Aidian Oy
FI-MF-000023611 · Finland · Espoo
Aidian Oy is registered in the European database on medical devices as a manufacturer, with 79 devices declared. It is also registered as a device establishment with the U.S. FDA.
What this manufacturer declares
Devices declared under this manufacturer
- APO B
- Aidian LF SARS-CoV-2 Ag Test
- Albumin Reagent
- Complement C4 Reagent
- Immunoglobulin G Reagent
- Lipoprotein (a)
- Protein Control
- QuikRead go CRP
- QuikRead go CRP Control Set
- QuikRead go Hb Control
- QuikRead go iFOBT
- UniQ ICTP RIA
Showing 12 of 79 declared devices.
Catalogue references include 141154, 145217, 151051, 154980, 67249, 67748.
European nomenclature codes declared: W0102160601, W0201020205, W010302080501, W0104010703, W0501010280, W0102160601,W0103010601.
United States market access
| FDA establishment register | Registered with FDA |
|---|---|
| Matched entry | AIDIAN OY (FI) · FDA 9610102 |
| Devices in EUDAMED | 79 |
| Country of registration | Finland |
Device-level evidence
| Devices with a numeric GTIN | 79 |
|---|---|
| Found in the U.S. device database | 4 |
| Share | 5.1 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: United States only. Aidian Oy is registered in the United States but was not found in the Canadian register.